BioCentury
ARTICLE | Company News

TCR2 to manufacture T cell therapies at CGT Catapult

March 29, 2019 6:46 PM UTC

TCR2 will work with Cell and Gene Therapy Catapult (London, U.K.) to manufacture the biotech's TCR Fusion Construct T cells therapies...

BCIQ Company Profiles

TCR2 Therapeutics Inc.